In Brief: FDA Antiviral Drugs Advisory Committee
Executive Summary
FDA Antiviral Drugs Advisory Committee: Will discuss liposomal antifungal agents during April 3-4 gathering at FDA's Parklawn Building, Conference Rooms D & E. On April 3, open committee discussion is scheduled from 8-11:30 a.m. and 2:30-5:30 p.m. The advisory committee will meet in closed session April 4, according to a March 16 Federal Register notice...